Kalevi Pyörälà
About
In The Last Decade
Kalevi Pyörälà
223 papers receiving 32.2k citations
Hit Papers
Peers
Comparison fields: 5 of 179
- Endocrinology, Diabetes and Metabolism 15.1k
- Cardiology and Cardiovascular Medicine 12.8k
- Surgery 12.7k
- Epidemiology 4.6k
- Economics and Econometrics 3.6k
Countries citing papers authored by Kalevi Pyörälà
This map shows the geographic impact of Kalevi Pyörälà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kalevi Pyörälà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kalevi Pyörälà more than expected).
Fields of papers citing papers by Kalevi Pyörälà
This network shows the impact of papers produced by Kalevi Pyörälà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kalevi Pyörälà. The network helps show where Kalevi Pyörälà may publish in the future.
Co-authorship network of co-authors of Kalevi Pyörälà
This figure shows the co-authorship network connecting the top 25 collaborators of Kalevi Pyörälà. A scholar is included among the top collaborators of Kalevi Pyörälà based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kalevi Pyörälà. Kalevi Pyörälà is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Estimation of ten-year risk of combined fatal and non fatal cardiovascular events: the SCOREplus study | 0 |
| 2 | 41 | |
| 3 | 28 | |
| 4 | 13 | |
| 5 | Variation in the fatty acid binding protein 2 gene is not associated with markers of metabolic syndrome in patients with coronary heart disease. | 24 |
| 6 | High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men | 143 |
| 7 | 328 | |
| 8 | Prevention of coronary heart disease in clinical practice | 48 |
| 9 | 137 | |
| 10 | 5 | |
| 11 | 55 | |
| 12 | [Prevention of coronary disease in clinical practice. Recommendations of the Task-Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension]. | 9 |
| 13 | Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) breakdown → | 6928 |
| 14 | 24 | |
| 15 | 175 | |
| 16 | 0 | |
| 17 | 3 | |
| 18 | 37 | |
| 19 | 31 | |
| 20 | 15 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.